What evidence suggests that calcium channel blockers may have benefits in reducing BP variability?
Recent evidence suggests that intraindividual variability in BP may confer risk beyond that caused by mean elevations in BP alone. There is further observational evidence that calcium channel blockers may have benefits in reducing BP variability that are not present with -blockers and that these benefits may provide additional benefits in stroke risk reduction.